Corvus Pharmaceuticals

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. With accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.

Corvus Pharmaceuticals headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Biopharma sector. The company focuses on Biotechnology and has secured $17.7B in funding across 72 round(s). With a team of 11-50 employees, Corvus Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Corvus Pharmaceuticals, raised $33.5M. Discover more about their projects, partnerships, and impact on our platform.